Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.43 |
| ▸ | UBA2 | Q9UBT2 | 1/20 | 0.43 |
| ▸ | F2 | P00734 | 2/20 | 0.42 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.42 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.42 |
| ▸ | TMPRSS6 | Q8IU80 | 2/20 | 0.42 |
| ▸ | ST14 | Q9Y5Y6 | 2/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.42 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6418566 | 0.98 | PRSS1 (0.46) | ALDH1A1MAPTPRSS1CA1CA2 | |
| SCHEMBL5712390 | 0.98 | PRSS1 (0.46) | ALDH1A1MAPTPRSS1CA1CA2 | |
| SCHEMBL5712397 | 0.98 | PRSS1 (0.46) | ALDH1A1MAPTPRSS1CA1CA2 | |
| SCHEMBL31475206 | 0.90 | ALDH1A1 (0.50) | ALDH1A1PRSS1CA2SAE1UBA2 | |
| SCHEMBL11500089 | 0.90 | MGLL (0.50) | LOXL2GAAABCG2CYP2A6 | |
| SCHEMBL23961158 | 0.89 | ALDH1A1 (0.49) | ALDH1A1PRSS1SAE1UBA2F2 | |
| SCHEMBL11475163 | 0.89 | MGLL (0.52) | LOXL2GAAABCG2CYP2A6 | |
| SCHEMBL11465958 | 0.89 | MGLL (0.52) | LOXL2GAAABCG2CYP2A6 | |
| SCHEMBL5283982 | 0.89 | MGLL (0.52) | LOXL2GAAABCG2CYP2A6 | |
| SCHEMBL11177848 | 0.89 | ALDH1A1 (0.49) | ALDH1A1PRSS1SAE1UBA2F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021483-A1 | Amidine derivatives for treating amyloidosis | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2007-01-25 | — | — | US | disclosed |
| EP-1715857-A1 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | Neurochem (International) Limited (CH) | 2006-11-02 | — | — | EP | disclosed |
| EP-1572129-A2 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2005-09-14 | — | — | EP | disclosed |
| WO-2005079780-A1 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2005-09-01 | — | — | WO | disclosed |
| US-20040147531-A1 | Amidine derivatives for treating amyloidosis | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2004-07-29 | — | — | US | disclosed |
| EP-1420773-A1 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | Neurochem (International) Limited (CH) | 2004-05-26 | — | — | EP | disclosed |
| US-20040006092-A1 | Amidine derivatives for treating amyloidosis | NEUROCHEM, INC. (CA) | 2004-01-08 | — | — | US | disclosed |
| WO-2003103598-A2 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2003-12-18 | — | — | WO | disclosed |
| WO-2003017994-A1 | AMIDINE DERIVATIVES FOR TREATING AMYLOIDOSIS | NEUROCHEM (INTERNATIONAL) LIMITED (CH) | 2003-03-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147531-A1 | Amidine derivatives for treating amyloidosis | APP, IAPP, HTT | ALDH1A1 2054/4885MAPT 11/4885PRSS1 1919/4885 |
| US-20040006092-A1 | Amidine derivatives for treating amyloidosis | APP, IAPP, HTT | ALDH1A1 2054/4885MAPT 11/4885PRSS1 1919/4885 |
| US-20070021483-A1 | Amidine derivatives for treating amyloidosis | APP, IAPP, GRN | ALDH1A1 2283/4885MAPT 10/4885PRSS1 2062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.